ArticleBMJ open2024

Safety and efficacy of individual target transcranial magnetic stimulation to stimulate the most negative correlate of DLPFC-pgACC in the treatment of major depressive disorder: study protocol of a double-blind, randomised controlled trial.

Nian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.